$XMTR

Weymouth Katharine sold $948K of XMTR

Weymouth Katharine sold 10,000 shares of Xometry, Inc. (XMTR) at an average of $94.77 ($94.30–$95.23, $0.95M total) across 2 trades over 2026-08-28 to 2026-08-31.

Original reporting
SEC EDGAR · Weymouth Katharine
Published Aug 31, 2026, 8:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$XMTR
Neutral
medium confidence
Mentioned
$XMTR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$XMTRNeutralLow
01

Why it matters

The disclosed sale is the primary new fact; no other material news in the filing.

02

Market read

A routine insider sale with modest size; limited trading relevance.

03

What to watch

Potential tax planning or diversification needs of the director.

Relevance 5/10Novelty 4/10Timing: after market close 2026-08-31

Background

Form 4 filings disclose insider transactions; directors' sales are monitored for sentiment.

Company-level read

Ticker impact

$XMTRNeutralMedium confidence
Context

Director Katharine Weymouth sold 10,000 shares for $947,668, reducing her stake to 35,345 shares.

Expected impact

Limited short-term impact; price may dip slightly on volume.

Evidence & confidence

Insider sales by directors can be viewed as a negative signal, yet the transaction size (~$0.95M) is small for a mid‑cap like Xometry.

Market effects

Minimal; does not affect broader manufacturing services sector.

None

None

Counterpoint

The sale could be unrelated to company outlook; may present a buying opportunity if fundamentals remain strong.

Key entities

  • Xometry, Inc.

    US-listed manufacturing marketplace (ticker XMTR).

  • Katharine Weymouth

    Director of Xometry who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$XMTRMedAI 8/10

Six Montgomery County companies attract more than $566 million in capital investment – WTOP News

Six Montgomery County companies raised over $566 million in Q3. Forbright (Nasdaq) completed an IPO, raising $142.2 million. Xometry (Nasdaq) announced a $225 million secondary offering. RegenxBio (Nasdaq) raised $90.04 million in a public offering. Georgiamune secured $92.69 million in venture funding. Arculus Solutions raised $1.95 million in Seed-1 funding. Jesse & Ben raised $15 million in Series A funding.

$XMTRHighAI 9/10

Xometry (XMTR) Q2 2026 Earnings Call Transcript

Xometry (XMTR) reported Q2 2026 revenue of $229.3 million, up 41% year over year, with marketplace revenue of $215.4 million (+45%). Adjusted EBITDA was $14.1 million, and non-GAAP net income was $9.9 million. The company raised Q3 2026 revenue guidance to $234 million to $236 million and full-year 2026 revenue growth to 33% to 34%.

$XMTRMed

Xometry, Inc. Q2 2026 Earnings Call Summary

Xometry, Inc. reported Q2 2026 results and said revenue growth accelerated for a fourth straight quarter, driven by a product-led shift toward an AI ecosystem. It cited improved CNC cost prediction accuracy (+~15%), record 175 net new enterprise accounts over $50,000, and reduced ad spend to 3.4% of revenue. Full-year 2026 revenue growth guidance raised to 33%-34% and marketplace gross margin target 35%-40%. Cash was $517M after a $248M follow-on and $50M Siemens investment.

$XMTRHighAI 9/10

Xometry, Inc.: Xometry Reports Record Second Quarter 2026 Results

Xometry (NASDAQ: XMTR) reported Q2 2026 results: revenue rose 41% to $229 million, with marketplace revenue up 45% to $215 million. Gross profit increased 34% to $87.2 million and Adjusted EBITDA rose $10.2 million to $14.1 million. Cash and equivalents were $517 million after a June equity offering. Q3 guidance calls for $234-$236 million revenue and $16-$17 million Adjusted EBITDA.